New Bubbleroom Sweden AB
STO:BBROOM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
New Bubbleroom Sweden AB
STO:BBROOM
|
SE |
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
CN |
|
First Horizon Corp
NYSE:FHN
|
US |
|
Gea Grenobloise Electronique Automatisme SA
PAR:GEA
|
FR |
|
Alembic Pharmaceuticals Ltd
NSE:APLLTD
|
IN |
|
Valiant Holding AG
SIX:VATN
|
CH |
Income Statement
Earnings Waterfall
New Bubbleroom Sweden AB
Income Statement
New Bubbleroom Sweden AB
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
273
N/A
|
399
+46%
|
311
-22%
|
439
+41%
|
439
0%
|
443
+1%
|
448
+1%
|
446
0%
|
446
+0%
|
438
-2%
|
439
+0%
|
448
+2%
|
448
+0%
|
440
-2%
|
441
+0%
|
433
-2%
|
430
-1%
|
425
-1%
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
(110)
|
(153)
|
(115)
|
(160)
|
(160)
|
(161)
|
(159)
|
(155)
|
(157)
|
(154)
|
(156)
|
(157)
|
(154)
|
(152)
|
(154)
|
(155)
|
(157)
|
(155)
|
|
| Gross Profit |
163
N/A
|
246
+51%
|
196
-21%
|
280
+43%
|
278
0%
|
282
+1%
|
289
+2%
|
291
+1%
|
289
0%
|
284
-2%
|
283
0%
|
290
+3%
|
294
+1%
|
288
-2%
|
286
-1%
|
277
-3%
|
273
-2%
|
269
-1%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(168)
|
(252)
|
(204)
|
(285)
|
(298)
|
(307)
|
(314)
|
(319)
|
(316)
|
(310)
|
(314)
|
(319)
|
(315)
|
(303)
|
(301)
|
(293)
|
(291)
|
(290)
|
|
| Selling, General & Administrative |
(32)
|
(47)
|
(37)
|
(51)
|
(53)
|
(54)
|
(55)
|
(55)
|
(55)
|
(56)
|
(56)
|
(57)
|
(57)
|
(54)
|
(54)
|
(54)
|
(54)
|
(59)
|
|
| Depreciation & Amortization |
(1)
|
(2)
|
(2)
|
(2)
|
(4)
|
(4)
|
(5)
|
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
|
| Other Operating Expenses |
(135)
|
(203)
|
(165)
|
(231)
|
(241)
|
(249)
|
(254)
|
(257)
|
(254)
|
(247)
|
(249)
|
(252)
|
(248)
|
(239)
|
(237)
|
(229)
|
(228)
|
(221)
|
|
| Operating Income |
(6)
N/A
|
(6)
-5%
|
(8)
-34%
|
(5)
+37%
|
(19)
-276%
|
(25)
-30%
|
(25)
-2%
|
(28)
-10%
|
(27)
+5%
|
(27)
-1%
|
(31)
-18%
|
(28)
+11%
|
(21)
+24%
|
(15)
+29%
|
(14)
+6%
|
(15)
-6%
|
(19)
-24%
|
(21)
-10%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(7)
N/A
|
(7)
-7%
|
(9)
-26%
|
(6)
+29%
|
(21)
-226%
|
(27)
-30%
|
(28)
-2%
|
(30)
-10%
|
(29)
+5%
|
(29)
-2%
|
(33)
-12%
|
(29)
+11%
|
(22)
+24%
|
(18)
+20%
|
(15)
+13%
|
(16)
-7%
|
(20)
-22%
|
(24)
-18%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(7)
|
(7)
|
(9)
|
(7)
|
(21)
|
(27)
|
(28)
|
(30)
|
(29)
|
(29)
|
(33)
|
(29)
|
(22)
|
(18)
|
(15)
|
(16)
|
(20)
|
(24)
|
|
| Net Income (Common) |
(7)
N/A
|
(7)
-1%
|
(9)
-25%
|
(7)
+29%
|
(21)
-220%
|
(27)
-29%
|
(28)
-2%
|
(30)
-10%
|
(29)
+5%
|
(29)
-2%
|
(33)
-12%
|
(29)
+11%
|
(22)
+23%
|
(18)
+21%
|
(15)
+13%
|
(16)
-7%
|
(20)
-22%
|
(24)
-18%
|
|
| EPS (Diluted) |
-0.48
N/A
|
-0.48
N/A
|
-0.6
-25%
|
-0.43
+28%
|
-1.35
-214%
|
-1.74
-29%
|
-1.78
-2%
|
-1.95
-10%
|
-1.85
+5%
|
-1.89
-2%
|
-2.11
-12%
|
-1.88
+11%
|
-1.44
+23%
|
-1.14
+21%
|
-0.98
+14%
|
-1.05
-7%
|
-1.28
-22%
|
-1.51
-18%
|
|